These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
583 related articles for article (PubMed ID: 29325247)
1. [Impact of PRDM1 gene inactivation on C-MYC regulation in diffuse large B-cell lymphoma]. Zhang XY; Ma ZP; Cui WL; Pang XL; Chen R; Wang L; Zhang W; Li XX Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):25-31. PubMed ID: 29325247 [No Abstract] [Full Text] [Related]
2. [Potential mechanism and prognostic value of promoter methylation of PRDM1 gene in diffuse large B cell lymphoma]. Zhang XY; Ma ZP; Cui WL; Chen R; Glinaer A; Miao N; Li XX Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):831-837. PubMed ID: 28056297 [No Abstract] [Full Text] [Related]
3. [Primary gastrointestinal diffuse large B-cell lymphoma: an immunohistochemical and prognostic study of 90 cases]. Lin L; Min M; Bi CF; Wang XQ; Luo TY; Zhao S; Zhang WY; Liu WP Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):220-6. PubMed ID: 21615994 [TBL] [Abstract][Full Text] [Related]
4. [Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens]. Yin WJ; Zhu X; Yang HY; Sun WY; Wu MJ Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):32-38. PubMed ID: 29325248 [No Abstract] [Full Text] [Related]
5. Clinical Significance of Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907 [No Abstract] [Full Text] [Related]
6. [Immunophenotyping and molecular genetic analysis of diffuse large B-cell lymphoma]. Han YS; Xue YQ; Yang HY; Zhang J; Pan JL Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Apr; 30(2):143-7. PubMed ID: 23568722 [TBL] [Abstract][Full Text] [Related]
7. Blimp-1 protein and Hans classification on prognosis of diffuse large B-cell lymphoma and their interrelation. Song Y; Cao Z; Li L; Zhang HT; Zhang X Chin J Cancer; 2010 Sep; 29(9):781-6. PubMed ID: 20800019 [TBL] [Abstract][Full Text] [Related]
8. Dysregulated MDR1 by PRDM1/Blimp1 Is Involved in the Doxorubicin Resistance of Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma. Qing K; Jin Z; Xu Z; Wang W; Li X; Zhang Y; Wang L; Zhu H; Xiang R; Wu S; Li R; Jiang G; Xue K; Li J Chemotherapy; 2022; 67(1):12-23. PubMed ID: 34844236 [TBL] [Abstract][Full Text] [Related]
9. Primary central nervous system diffuse large B-cell lymphoma shows an activated B-cell-like phenotype with co-expression of C-MYC, BCL-2, and BCL-6. Li X; Huang Y; Bi C; Yuan J; He H; Zhang H; Yu Q; Fu K; Li D Pathol Res Pract; 2017 Jun; 213(6):659-665. PubMed ID: 28552541 [TBL] [Abstract][Full Text] [Related]
10. [Analysis of the immunohistochemical subtypes and prognosis of primary diffuse large B cell lymphoma of the central nervous system]. Min M; Lin L; Bi CF; Wang XQ; Luo TY; Zhao S; Zhang WY; Liu WP Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):110-6. PubMed ID: 22780928 [TBL] [Abstract][Full Text] [Related]
11. [Immunophenotypes and prognosis of diffuse large B-cell lymphoma: a study of 500 cases]. Luo DL; Liu YH; Zhuang HG; Li L; Xu FP; Zhang F; Luo XL; Xu J Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):235-9. PubMed ID: 21615996 [TBL] [Abstract][Full Text] [Related]
12. [Significance of myc gene rearrangement and its correlation with prognosis in diffuse large B cell lymphoma]. Zhang HW; Chen ZW; He JX; Zheng YP; Han WE; Zhao ZQ; Bai W; Wang JF Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):119-23. PubMed ID: 23714666 [TBL] [Abstract][Full Text] [Related]
13. The genetic deletion and protein expression of PRDM1 and its clinical implications in diffuse large B cell lymphoma: A retrospective cohort study in China. Nong L; Zheng Y; Li X; Li D; Liang L; Wang W; Li T Pathol Res Pract; 2022 May; 233():153860. PubMed ID: 35429891 [TBL] [Abstract][Full Text] [Related]
14. [Expression of microRNA-223 and its clinicopathologic correlation in diffuse large B-cell lymphoma]. Yao XX; Wang JF; Wang YH; Gao N Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):366-70. PubMed ID: 22932402 [TBL] [Abstract][Full Text] [Related]
15. [Correlation of BCL-6, MYC and p53 gene abnormalities with immunological subtypes and prognosis of diffuse large B-cell lymphoma]. Sun GX; Cao XS; Li Q; Wang ZL Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Oct; 29(5):576-81. PubMed ID: 23042398 [TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic and immunohistochemical study of intra-abdominal non-Hodgkin B-cell lymphoma occurring in children]. Yang WP; Zhu CD; Gong LP; Lü BB; Zou Y; Zhong HS; Xiao Q; Wu Y; Xu HY; Zeng ST; Huang H Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):759-64. PubMed ID: 20079016 [TBL] [Abstract][Full Text] [Related]
17. [Clinicopathologic features and expression of OCT4 protein in testicular diffuse large B cell lymphoma]. Chen YP; Zhu WF; Chen LF; Lu JP; He TM; Fu WD; Xu CW; Chen G Zhonghua Bing Li Xue Za Zhi; 2017 Jun; 46(6):383-387. PubMed ID: 28591984 [No Abstract] [Full Text] [Related]
18. [Activation and clinicopathologic significance of AKT/mTOR signaling pathway in diffuse large B-cell lymphoma]. Yu BH; Zhou XY; Xiao XY; Yan SY; Qin T; Shi DR Zhonghua Bing Li Xue Za Zhi; 2009 Jan; 38(1):35-41. PubMed ID: 19489223 [TBL] [Abstract][Full Text] [Related]
19. [Expression of CD68, cyclin D1 and rearrangement of bcl-6 gene are adverse prognostic factors in diffuse large B-cell lymphoma]. Liang X; Wang J; Bai W; Sun R Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):559-64. PubMed ID: 26705179 [TBL] [Abstract][Full Text] [Related]
20. [State of chromosome 3q27 and different subtypes of diffuse large B-cell lymphoma and their prognostic correlation]. Li Y; Wang GP; Xi YF; Wang JF; Bai W Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):231-6. PubMed ID: 19575893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]